Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Is The Allogeneic Cell Therapy Market Expected To Grow In Terms Of Size?

The market size for allogeneic cell therapy has experienced significant expansion in recent times. Its growth is expected to increase from $1.08 billion in 2024 to $1.2 billion in 2025, with a compound annual growth rate (CAGR) of 11.5%. Factors contributing to this growth during the historical period include an amplified emphasis on customizing donor cell selection and genetic alterations, a rise in population size, an increase in the worldwide prevalence of chronic diseases, heightened awareness, and a surge in partnerships for the development of biosimilars.

In the coming years, the allogeneic cell therapy market is projected to experience substantial expansion. The market is estimated to reach $1.81 billion by 2029, with a compound annual growth rate (CAGR) of 10.8%. The predicted growth during the forecast period could be due to the rising need for more sophisticated healthcare treatments, the burgeoning demand for innovative allogeneic cell therapies, an increasing number of clinical trials, contributions from a growing patient base, and escalating income levels. The forecast period will also see prominent trends such as technological advancements, strategic partnerships, collaborations between major companies, mergers and acquisitions, and product launches.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15976&type=smp

What Market Forces Are Contributing To The Growth Of The Allogeneic Cell Therapy Market?

The growth of the allogeneic cell therapy market is projected to be fueled by the escalating incidence of chronic illnesses. Chronic illnesses are long-term conditions that usually need continuous medical care and can restrict day-to-day activities or quality of life. The increase in chronic diseases can be attributed to changed habits, genetic factors, and exposure to air pollutants, toxins and chemicals. Therapies using allogeneic cells have tremendous potential to treat a variety of chronic diseases by employing healthy cells from a donor in order to rectify, substitute, or adjust the malfunctioning cells or tissues in the recipient. For example, in January 2023, the US-based National Center for Biotechnology Information (NCBI), forecasted a 99.5% surge by 2050 in the number of individuals aged 50 and over afflicted with one or more chronic ailments, rising from 71.52 million in 2020 to 142.66 million. Consequently, the growing occurrence of chronic illnesses bolsters the growth of the allogeneic cell therapy market.

How Is The Allogeneic Cell Therapy Market Segmented Across Key Categories?

The allogeneic cell therapymarket covered in this report is segmented –

1) By Type: Stem Cell Therapies; Non-Stem Cell Therapies

2) By Therapeutic Area: Hematological Disorders; Dermatological Disorders; Other Therapeutic Area

3) By End User: Hospitals; Specialty Clinics; Research Organizations

Subsegments:

1) By Stem Cell Therapies: Hematopoietic Stem Cell Therapy (Hematopoietic Stem Cells); Mesenchymal Stem Cell Therapy (MSC-Based Therapies); Induced Pluripotent Stem Cells (iPSC-Based Therapies); Neural Stem Cell Therapy; Other Stem Cell Therapies

2) By Non-Stem Cell Therapies: T-cell Therapies; Natural Killer (NK) Cell Therapies; Dendritic Cell Therapies; Other Non-Stem Cell Therapies

What Key Trends Are Driving Growth In The Allogeneic Cell Therapy Market?

Major players in the allogeneic cell therapy market are concentrating on creating innovative solutions like cell processing platforms, in an attempt to consolidate their market positions. Cell processing platforms represent system technologies employed in the preparation and manipulation of cells for therapeutic uses. They cover the gamut from isolation and purification to expansion, modification, and quality control to ensure clinical suitability of cells. An example is the partnership that took place in March 2024 between Getinge, a healthcare firm from Sweden and a UK-based biotech company, CellRev, to introduce Livit ACE, a Continuous Cell Processing (Adherent Cell Expansion) platform. This advanced platform combines sophisticated automation and bioprocessing technologies, considerably boosting the efficacy and scalability of cell production. Noteworthy features of the platform include state-of-the-art cell isolation and purification systems ensuring high cell purity and viability, robust expansion capabilities for producing large volumes of therapeutic cells, advanced genetic modification tools for accurate cell engineering, and stringent quality control checks to safeguard the safety and effectivity of the cell products.

Who Are The Major Stakeholders Operating In The Allogeneic Cell Therapy Market?

Major companies operating in the allogeneic cell therapy market are Novartis AG, Bristol Myers Squibb Company, Takeda Pharmaceutical Company Limited, Bluebird Bio Inc., Poseida Therapeutics Inc., Fate Therapeutics Inc., Fortress Biotech Inc., Sorrento Therapeutics Inc., Eureka Therapeutics Inc., Juno Therapeutics Inc., Adaptimmune Therapeutics plc, Cellectis SA, TrakCel Ltd., Promab Biotechnologies Inc., Ziopharm Oncology Inc., Allogene Therapeutics Inc., Century Therapeutics Inc., Autolus Therapeutics plc, Bellicum Pharmaceuticals Inc., Minerva Biotechnologies Corporation, Celyad SA, TILT Biotherapeutics Ltd., CRISPR Therapeutics AG

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/allogeneic-cell-therapy-global-market-report

How Do Regional Dynamics Influence The Allogeneic Cell Therapy Market Performance?

North America was the largest region in the allogeneic cell therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the allogeneic cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15976&type=smp

Browse Through More Reports Similar to the Global Allogeneic Cell Therapy Market 2025, By The Business Research Company

Cells Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Stem Cells Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Cell Therapy Technologies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model